Cited by 331Neurotransmitter Receptor Influence on BehaviorTreatment of Major DepressionGenetic Associations and Epidemiology

The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

Porcelli, Stefano, Fabbri, Chiara, Serretti, Alessandro·2012·European Neuropsychopharmacology

DOI 10.1016/j.euroneuro.2011.10.003

Open this paper in CoChat — free account

Abstract

In the last decade the serotonin transporter gene promoter polymorphism (5-HTTLPR) was likely the most studied genetic variant as predictor of antidepressant response. Nevertheless results are not consistent across studies and previous meta-analysis, since various factors seem to modulate its effect on antidepressant response. With the aim of clarifying this issue, we systematically reviewed literature, selecting 33 studies for an exploratory analysis without any a priori hypothesis. Then we analyzed separately 19 studies performed on Caucasians and 11 on Asians. We tested two phenotypes--remission and response rates--and three genotype comparisons--ll versus ls/ss, ss versus ll/ls and ll versus ss - using the Cochrane review manager. Evaluations were performed separately for SSRIs and mixed/other drugs. Possible clinical modulators were investigated. In the exploratory analysis, we found an association between l allele and l/l genotype and remission. When the analysis was split for ethnic group, in Caucasians we found an association between l allele and both response (OR = 1.58, C.I. 1.16-2.16, p = 0.004), and remission (OR = 1.53, C.I. 1.14-2.04, p = 0.004) in the SSRI group. Only a marginal association between l allele and remission (OR = 1.41, C.I. 1.02-1.95, p = 0.04) survived pooling together mixed antidepressant treatments. In Asians, a small effect of 5-HTTLPR on remission for mixed antidepressants was detected (OR = 2.10, C.I. 1.15-3.84, p = 0.02). Gender, age and age at onset modulated the association in Caucasians. Gender, age and depression severity at baseline modulated the association in Asians. In conclusion, in Caucasians 5-HTTLPR may be a predictor of antidepressant response and remission, while in Asians it does not appear to play a major role.

Integrity signals

Registry

Crossref · 10.1016/j.euroneuro.2011.10.003

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Untitled work
(2014) · Medical Entomology and Zoology · Cited by 17,633
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Meta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.
Hu, X.-Z., Lipsky, R., Zhu, G., Akhtar, L. A., Taubman, J., Greenberg, B., Xu, K., Arnold, P., Richter, M., Kennedy, J., et al. (2006) · American Journal of Human Genetics · doi:10.1086/503850 · Cited by 1,215
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 728
The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants
Nakamura, M., Ueno, S., Sano, A., & Tanabe, H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000698 · Cited by 636
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
Smeraldi, E., Zanardi, R., Benedetti, F., Bella, D. D., Pérez, J., & Catalano, M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000425 · Cited by 614
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients
Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529
Self-citation
Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder: Results From a European Multicenter Study
Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0713 · Cited by 521
Self-citation
A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety.
Schinka, J. A., Busch, R. M., & Robichaux-Keene, N. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001405 · Cited by 521
Understanding heterogeneity in meta-analysis: the role of meta-regression
Baker, W. L., Michael White, C., Cappelleri, J. C., Kluger, J., Coleman, C. I., & From the Health Outcomes, P. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02168.x · Cited by 492
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M., & Serretti, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.116 · Cited by 450
Self-citation
Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression
Pollock, B. G. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00132-9 · Cited by 415
The economic burden of depression and the cost-effectiveness of treatment
Wang, P. S., Simon, G., & Kessler, R. C. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.139 · Cited by 403
Serotonin transporter gene polymorphism and antidepressant response
Kim, D. K., Lim, S., Lee, S., Sohn, S. E., Kim, S., Hahn, C. G., & Carroll, B. J. (2000) · Neuroreport · doi:10.1097/00001756-200001170-00042 · Cited by 399
Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene
Zanardi, R., Benedetti, F., Bella, D. D., Catalano, M., & Smeraldi, E. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00021 · Cited by 309
Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder
Kunugi, H., Hattori, M., Kato, T., Tatsumi, M., Sakai, T., Sasaki, T., Hirose, T., & Nanko, S. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000334 · Cited by 305
Gender Issues in Depression
Grigoriadis, S., & Robinson, G. E. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653294 · Cited by 285
Effects of the Serotonin Transporter Gene Promoter Polymorphism onMirtazapine and Paroxetine Efficacy and Adverse Events in Geriatric MajorDepression
Murphy, G. M., Hollander, S. B., Rodrigues, H. E., Kremer, C. M. E., & Schatzberg, A. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1163 · Cited by 275
Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients
Yoshida, K., Ito, K., Sato, K., Takahashi, H., Kamata, M., Higuchi, H., Shimizu, T., Itoh, K., Inoue, K., Tezuka, T., et al. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00287-1 · Cited by 226
Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-httlpr in delusional and nondelusional depression
Zanardi, R., Serretti, A., Rossini, D., Franchini, L., Cusin, C., Lattuada, E., Dotoli, D., & Smeraldi, E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01118-0 · Cited by 224
Self-citation
Sequence Analysis of the Serotonin Transporter and Associations with Antidepressant Response
Kraft, J. B., Slager, S. L., McGrath, P. J., & Hamilton, S. P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.048 · Cited by 224
Serotonin Transporter Gene Variants and Behavior: A Comprehensive Review
Serretti, A., Calati, R., Mandelli, L., & Ronchi, D. D. (2006) · Current Drug Targets · doi:10.2174/138945006779025419 · Cited by 224
Self-citation
Association Between a Functional Serotonin Transporter Promoter Polymorphism and Citalopram Treatment in Adult Outpatients With Major Depression
Hu, X., Rush, A. J., Charney, D. S., Wilson, A. F., Sorant, A. J. M., Papanicolaou, G., D, M. F. M., Trivedi, M. H., Wisniewski, S. R., Laje, G., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.783 · Cited by 219
Tolerability and adherence issues in antidepressant therapy
Masand, P. S. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80220-5 · Cited by 215
Monoamine Transporter Gene Polymorphisms and Antidepressant Response in Koreans With Late-Life Depression
Kim, H. R., Lim, S., Kim, S., Kim, J., Chang, Y. H., Carroll, B. J., & Kim, D. K. (2006) · JAMA · doi:10.1001/jama.296.13.1609 · Cited by 202
Initial conditions of serotonin transporter kinetics and genotype: influence on ssri treatment trial outcome
Rausch, J. L., Johnson, M. E., Fei, Y.-J., Li, J. Q., Shendarkar, N., Hobby, H. M., Ganapathy, V., & Leibach, F. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01283-5 · Cited by 193
Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder
Hong, C.-J., Chen, T., Yu, Y. W.-Y., & Tsai, S.-J. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500340 · Cited by 189
Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression
Minov, C., Baghai, T. C., Schüle, C., Zwanzger, P., Schwarz, M., Zill, P., Rupprecht, R., & Bondy, B. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01704-9 · Cited by 189
Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder
Rosenthal, N. E., Mazzanti, C. M., Barnett, R. L., Hardin, T. A., Turner, E. H., Lam, G. K. W., Ozaki, N., & Goldman, D. A. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000360 · Cited by 185
Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: Association with major depression and antidepressant response in Mexican-Americans
Dong, C., Wong, M.-L., & Licinio, J. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.92 · Cited by 182
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment
Perlis, R. H., Mischoulon, D., Smoller, J. W., Wan, Y. Y., Lamon‐Fava, S., Lin, K.-M., Rosenbaum, J. F., & D, M. F. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00424-4 · Cited by 177
Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review
Smits, K. M., Smits, L. J. M., Schouten, J., Stelma, F. F., Nelemans, P. J., & Prins, M. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001488 · Cited by 177
5-HTTLPR Polymorphism of the Serotonin Transporter Gene Predicts Non-Remission in Major Depression Patients Treated With Citalopram in a 12-Weeks Follow Up Study
Arias, B., Catalán, R., Gastó, C., Gutiérrez, B., & Fañanás, L. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095350.32154.73 · Cited by 174
Effects of the Serotonin Type 2A, 3A and 3B Receptor and the Serotonin Transporter Genes on Paroxetine and Fluvoxamine Efficacy and Adverse Drug Reactions in Depressed Japanese Patients
Kato, M., Fukuda, T., Wakeno, M., Fukuda, K., Okugawa, G., Ikenaga, Y., Yamashita, M., Takekita, Y., Nobuhara, K., Azuma, J., et al. (2006) · Neuropsychobiology · doi:10.1159/000094727 · Cited by 166
Depression: the benefits of early and appropriate treatment.
Halfin, A. (2007) · PubMed · Cited by 161
Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms
Yoshida, K., Takahashi, H., Higuchi, H., Kamata, M., Ito, K., Sato, K., Naito, S., Shimizu, T., Itoh, K., Inoue, K., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1575 · Cited by 160
Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.
Kraft, J., Peters, E. J., Slager, S., Jenkins, G. D., Reinalda, M. S., McGrath, P., & Hamilton, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.017 · Cited by 157
Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
Franchini, L., Serretti, A., Gasperini, M., & Smeraldi, E. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00004-1 · Cited by 156
Self-citation
The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms
Goldman, N., Glei, D. A., Lin, Y.-H., & Weinstein, M. (2010) · Depression and Anxiety · doi:10.1002/da.20660 · Cited by 155
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder
Durham, L. K., Webb, S., Milos, P. M., Clary, C., & Seymour, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1562-3 · Cited by 149
Moderation of antidepressant response by the serotonin transporter gene
Huezo-Diaz, P., Uher, R., Smith, R. G., Rietschel, M., Henigsberg, N., Marušiˇ, A., Mors, O. N., Maier, W., Hauser, J., Souery, D., et al. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.062521 · Cited by 148
Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials
Machado, M., Iskedjian, M., Ruiz, I., & Einarson, T. R. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x132415 · Cited by 144
Interactive Effects of Sex and 5-HTTLPR on Mood and Impulsivity During Tryptophan Depletion in Healthy People
Walderhaug, E., Magnússon, A., Neumeister, A., Lappalainen, J., Lunde, H. A., Refsum, H., & Landrø, N. I. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.012 · Cited by 142
SLC6A4 variation and citalopram response
Mrazek, D. A., Rush, A. J., Biernacka, J. M., O’Kane, D. J., Cunningham, J. M., Wieben, E. D., Schaid, D. J., Drews, M. S., Courson, V. L., Snyder, K. A., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30816 · Cited by 140
Analysis of Association Between the Serotonin Transporter and Antidepressant Response in a Large Clinical Sample
Ballenger, J. C. (2008) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70773-4 · Cited by 123
Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region
Taylor, M. J., Sen, S., & Bhagwagar, Z. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.034 · Cited by 121
Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy
Wilkie, M. J. V., Smith, G. C., Day, R. K., Matthews, K., Smıth, D. J., Blackwood, D., Reid, I., & Wolf, C. R. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500491 · Cited by 117
Psychosocial and clinical predictors of response to pharmacotherapy for depression
Bagby, R. M., Ryder, A. G., & Cristi, C. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0243 · Cited by 115
A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder
Willeit, M., Praschak-Rieder, N., Neumeister, A., Zill, P., Leisch, F., Stastny, J., Hilger, E., Thierry, N., Konstantinidis, A., Winkler, D., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001392 · Cited by 114
Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein β3 subunit as predictors of response to fluoxetine and nortriptyline
Joyce, P. R., Mulder, R., Luty, S. E., McKenzie, J. M., Miller, A. L., Rogers, G. R., & Kennedy, M. A. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003663 · Cited by 107
A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment
Kirchheiner, J., Nickchen, K., Sasse, J., Bauer, M., Roots, I., & Brockmöller, J. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500398 · Cited by 94
Interaction between genetic polymorphisms and stressful life events in first episode depression
Bukh, J. D., Bock, C., Vinberg, M., Werge, T. M., Gether, U., & Kessing, L. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.023 · Cited by 93
When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study
Perlis, R. H., Patrick, A. R., Smoller, J. W., & Wang, P. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.50 · Cited by 82
Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders
Serretti, A., Cusin, C., Rossini, D., Artioli, P., Dotoli, D., & Zanardi, R. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30027 · Cited by 79
Self-citation
Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response
Min, W., Li, T., Ma, X., Li, Z., Yu, T., Gao, D. F., Zhang, B., Yun, Y., & Sun, X. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1550-3 · Cited by 76
Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities
Ng, C. H., Easteal, S., Tan, S. M. K., Schweitzer, I., Ho, B. K. W., & Aziz, S. A. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.02.015 · Cited by 75
Norepinephrine and Serotonin Transporter Genes: Impact on Treatment Response in Depression
Baffa, A., Hohoff, C., Baune, B. T., Müller‐Tidow, C., Tidow, N., Freitag, C. M., Zwanzger, P., Deckert, J., Arolt, V., & Domschke, K. (2010) · Neuropsychobiology · doi:10.1159/000317285 · Cited by 72
Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment
Lee, M.-S., Lee, H., Lee, H., & Ryu, S. (2004) · Psychiatric Genetics · doi:10.1097/01.ypg.0000107928.32051.11 · Cited by 71
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression
Maron, E., Tammiste, A., Kallassalu, K., Eller, T., Vasar, V., Nutt, D., & Metspalu, A. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.010 · Cited by 70
Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect?
Baune, B. T., Hohoff, C., Mortensen, L. S., Deckert, J., Arolt, V., & Domschke, K. (2007) · Depression and Anxiety · doi:10.1002/da.20433 · Cited by 64
The combination of duloxetine and bupropion for treatment-resistant major depressive disorder
Papakostas, G. I., Worthington, J. J., Iosifescu, D. V., Kinrys, G., Burns, A. M., Fisher, L. B., Homberger, C. H., Mischoulon, D., & D, M. F. M. (2006) · Depression and Anxiety · doi:10.1002/da.20181 · Cited by 61
Serotonin Transporter Polymorphisms and Side Effects in Antidepressant Therapy – A Pilot Study
Popp, J., Leucht, S., Heres, S., & Steimer, W. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.2.159 · Cited by 59
Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics
Maier, W., & Zobel, A. W. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-1004-z · Cited by 57
Mode of inheritance in mood disorder families according to fluvoxamine response
Serretti, A., Franchini, L., Gasperini, M., Rampoldi, R., & Smeraldi, E. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10117.x · Cited by 52
Self-citation
Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder
Ruhé, H. G., Ooteman, W., Booij, J., Michel, M. C., Moeton, M., Baas, F., & Schene, A. H. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32831a6a3a · Cited by 52
Interaction between SERTPR and stressful life events on response to antidepressant treatment
Mandelli, L., Marino, E., Pirovano, A., Calati, R., Zanardi, R., Colombo, C., & Serretti, A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.08.005 · Cited by 49
Self-citation
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders
Serretti, A., Chiesa, A., Calati, R., Perna, G., Bellodi, L., & Ronchi, D. D. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32831db2d7 · Cited by 48
Self-citation
Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder
Papakostas, G. I., McGrath, P. J., Stewart, J. W., Charles, D., Chen, Y., Mischoulon, D., Dording, C. M., & D, M. F. M. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2008.02.011 · Cited by 47
Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder
Kang, R.-H., Wong, M., Choi, M.-J., Paik, J., & Lee, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.05.018 · Cited by 47
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
Umene‐Nakano, W., Yoshimura, R., Ueda, N., Suzuki, A., Ikenouchi, A., Hori, H., Otani, K., & Nakamura, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109106899 · Cited by 46
Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder
Božina, N., Peleš, A. M., Šagud, M., Bilusic, H., & Jakovljević, M. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701308397 · Cited by 43
Serotonin Transporter Gene Polymorphisms and Sertraline Response in Major Depression Patients
Doğan, Ö., Yüksel, N., Ergün, M. A., Yılmaz, A., ILHAN, M. N., Karslioglu, H. E., Koç, A., & Menevşe, A. (2008) · Genetic Testing · doi:10.1089/gte.2007.0089 · Cited by 43
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients
Mandelli, L., Mazza, M., Martinotti, G., Nicola, M. D., Tavian, D., Colombo, E., Missaglia, S., Ronchi, D. D., Colombo, R., Janiri, L., et al. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.027 · Cited by 42
Self-citation
Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients
Lotrich, F. E., Pollock, B. G., Kirshner, M. A., Ferrell, R. F., & Reynolds, C. F. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0814 · Cited by 42
5-HTTLPR modulates antidepressant efficacy in depressed women
Gressier, F., Bouaziz-Amar, É., Verstuyft, C., Hardy, P., Becquemont, L., & Corruble, E. (2009) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32832cef0d · Cited by 41
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders
Serretti, A., Olgiati, P., Bajo, E., Bigelli, M., & Ronchi, D. D. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.572998 · Cited by 41
Self-citation
Rare genotype combination of the serotonin transporter gene associated with treatment response in severe personality disorder
Perroud, N. A., Salzmann, A., Sáiz, P. A., Baca‐García, E., Sarchiapone, M., García‐Portilla, M. P., Carli, V., Vaquero‐Lorenzo, C., Jaussent, I., Mouthon, D., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31118 · Cited by 38
Lithium Overcomes the Influence of 5-HTTLPR Gene Polymorphism on Antidepressant Response to Sleep Deprivation
Benedetti, F., Barbini, B., Bernasconi, A., Fulgosi, M. C., Campori, E., Colombo, C., Dallaspezia, S., Lorenzi, C., Pontiggia, A., Radaelli, D., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318167461e · Cited by 36
Serotonin transporter gene and response to lithium augmentation in depression
Stamm, T. J., Adli, M., Kirchheiner, J., Smolka, M. N., Kaiser, R., Tremblay, P., & Bauer, M. (2008) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3282f08a19 · Cited by 32
Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
Illi, A., Poutanen, O., Setälä-Soikkeli, E., Kampman, O., Viikki, M., Huhtala, H., Mononen, N., Haraldsson, S., Koivisto, P. A., Leinonen, E. V. J., et al. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0126-x · Cited by 30
Genetic polymorphisms in the treatment of depression: Speculations from an augmentation study using atomoxetine
Reimherr, F. W., Amsterdam, J. D., Dünner, D. L., Adler, L. A., Zhang, S., Williams, D. W., Marchant, B. K., Michelson, D., Nierenberg, A. A., Schatzberg, A. F., et al. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.01.005 · Cited by 29
Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients
Yoshimura, R., Umene‐Nakano, W., Suzuki, A., Ueda, N., Miyamoto, K., Ikenouchi, A., Hori, H., Otani, K., & Nakamura, J. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1043 · Cited by 28
Antidepressant response in the elderly
Mandelli, L., Serretti, A., Zanardi, R., Rossini, D., Ronchi, D. D., Tarricone, I., & Colombo, C. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.10.008 · Cited by 26
Self-citation
Pharmacogenetics of antidepressive treatment
Zobel, A. W., & Maier, W. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0091-4 · Cited by 25
Serotonin Transporter Gene Polymorphism Associated with Short-Term Treatment Response to Venlafaxine
Lee, S., Choi, T.-K., Lee, E. M., Seok, J., Lee, S. H., Lee, H. S., & Kim, S. J. (2010) · Neuropsychobiology · doi:10.1159/000319362 · Cited by 24
New Approaches to the Pharmacological Management of Major Depressive Disorder
Witkin, J. M., & Li, X. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57009-8 · Cited by 14
Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases
Serretti, A., Calati, R., Oasi, O., Ronchi, D. D., & Colombo, C. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-5 · Cited by 14
Self-citation
No predictors of antidepressant patient response to milnacipran were obtained using the three‐factor structures of the Montgomery and Åsberg Depression Rating Scale in Japanese patients with major depressive disorders
Higuchi, H., Sato, K., Yoshida, K., Takahashi, H., Kamata, M., Otani, K., & Yamaguchi, N. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01755.x · Cited by 8
THE PROGNOSIS OF ANTIDEPRESSIVE TREATMENTS: LONGITUDINAL AND GENETIC STUDIES.
Angst, J. (1965) · PubMed · Cited by 8

Sorted by citations

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Neurotransmitter deficits from frontotemporal lobar degeneration
Murley, A. G., & Rowe, J. B. (2017) · Brain · doi:10.1093/brain/awx327 · Cited by 211
Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
AB-GEN Collaborative Group, Pérez, V., Salavert, A., Espadaler, J., Tuson, M., Sáiz-Ruiz, J., Sáez-Navarro, C., Bobes, J., Baca‐García, E., Vieta, E., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1412-1 · Cited by 211
Pharmacogenetics in major depression: A comprehensive meta-analysis
Niitsu, T., Fabbri, C., Bentini, F., & Serretti, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.05.011 · Cited by 196
Self-citation

See all 331

Authors: Porcelli, S., Fabbri, C., & Serretti, A.
Affiliations: University of Bologna (IT)
Corresponding author: Serretti, Alessandro
ORCID: Porcelli, Stefano
Fabbri, Chiara
Serretti, Alessandro
Venue: European Neuropsychopharmacology
Publisher: Elsevier BV
Published: 2012-04
Volume: 22
Issue: 4
Pages: 239-258
ISSN: 0924-977X (ISSN-L)
DOI: 10.1016/j.euroneuro.2011.10.003
OpenAlex: W2035090322
Cited by: 331
References: 93
Citations by year: 2026: 4 · 2025: 11 · 2024: 8 · 2023: 18 · 2022: 18 · 2021: 24 · 2020: 19 · 2019: 20 · 2018: 31 · 2017: 27 · 2016: 42 · 2015: 33 · 2014: 27 · 2013: 36 · 2012: 13
FWCI: 2.32
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Neuropsychopharmacology (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: 5-HTTLPR, serotonin transporter gene, promoter polymorphism, antidepressant response, antidepressant remission, genetic predictors of treatment response, selective serotonin reuptake inhibitors, ethnic differences, Caucasians, Asians, age of onset, depression severity, sex differences
MeSH terms: Age Factors, Alleles, Antidepressive Agents, Depression, Female, Genotype, Humans, Male, Polymorphism, Genetic, Promoter Regions, Genetic, Remission Induction, Sex Factors, White People, Asian People, Serotonin Plasma Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks